Researchers’ disclosure of Lilly payments probed

Three Harvard Medical School doctors whose studies helped pave the way for the use of psychiatric drugs in children are being investigated for failing to properly disclose payments from several drugmakers, including Eli Lilly and Co., reports Bloomberg News.

The researchers initially said they received less than $80,000 from Lilly, which makes the antipsychotic drug Zyprexa as well as Strattera, a treatment for attention deficit disorder. But in a subsequent review, they claimed to have received $172,198; Lilly told Sen. Charles Grassley it had paid the researchers $259,756.